Osunprotafib (ABBV-CLS-484) Mechanism of Action: PTPN2 Inhibition in T Cell Research

Osunprotafib (ABBV-CLS-484) MOA:Targeting PTPN2/JAK-STAT Pathway for Solid Tumor Immunotherapy

🎯 check Osunprotafib (ABBV-CLS-484) product page

Osunprotafib (ABBV-CLS-484) is a potent, first-in-class, active-site competitive PTPN2 and PTPN1 inhibitor. It affects JAK-STAT and interferon signaling by preventing the dephosphorylation of key immune proteins, enhancing T cell activation and promoting robust anti-tumor immune responses.

Primary Applications and Mechanism of Action